Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Panaccione

Showing results (11-20 of 652) with videos related to

Pageof 66
Sort By:
Therapeutic Advances in Gastroenterology|December 25, 2010
Optimal use of biologics in the management of Crohn's diseaseRemo Panaccione, Subrata Ghosh
Expert Opinion on Biological Therapy|November 12, 2019
Anti-MADCAM therapy for ulcerative colitisSherman Picardo, Remo Panaccione
The Medical Clinics of North America|December 1, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Expert Opinion on Biological Therapy|June 14, 2008
Adalimumab for the treatment of Crohn's diseaseShane M Devlin, Remo Panaccione
Current Genetics|March 15, 2016
Functional analysis of the gene controlling hydroxylation of festuclavine in the ergot alkaloid pathway of Neosartorya fumigataYulia Bilovol, Daniel G Panaccione
Current Opinion in Gastroenterology|February 11, 2005
Medical therapy of Crohn diseaseRemo Panaccione, William J Sandborn
Gastroenterology Clinics of North America|November 17, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Therapeutic Advances in Gastroenterology|March 16, 2023
Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitisKenneth Ernest-Suarez, Remo Panaccione
Mycologia|March 29, 2012
Chemotypic and genotypic diversity in the ergot alkaloid pathway of Aspergillus fumigatusSarah L Robinson, Daniel G Panaccione
Expert Opinion on Biological Therapy|November 17, 2015
Vedolizumab for the treatment of ulcerative colitisNeal Shahidi, Brian Bressler, Remo Panaccione
Pageof 66

Showing results (11-20 of 652) with videos related to

Sort By:
Pageof 66
Therapeutic Advances in Gastroenterology|December 25, 2010
Optimal use of biologics in the management of Crohn's diseaseRemo Panaccione, Subrata Ghosh
Expert Opinion on Biological Therapy|November 12, 2019
Anti-MADCAM therapy for ulcerative colitisSherman Picardo, Remo Panaccione
The Medical Clinics of North America|December 1, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Expert Opinion on Biological Therapy|June 14, 2008
Adalimumab for the treatment of Crohn's diseaseShane M Devlin, Remo Panaccione
Current Genetics|March 15, 2016
Functional analysis of the gene controlling hydroxylation of festuclavine in the ergot alkaloid pathway of Neosartorya fumigataYulia Bilovol, Daniel G Panaccione
Current Opinion in Gastroenterology|February 11, 2005
Medical therapy of Crohn diseaseRemo Panaccione, William J Sandborn
Gastroenterology Clinics of North America|November 17, 2009
Evolving inflammatory bowel disease treatment paradigms: top-down versus step-upShane M Devlin, Remo Panaccione
Therapeutic Advances in Gastroenterology|March 16, 2023
Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitisKenneth Ernest-Suarez, Remo Panaccione
Mycologia|March 29, 2012
Chemotypic and genotypic diversity in the ergot alkaloid pathway of Aspergillus fumigatusSarah L Robinson, Daniel G Panaccione
Expert Opinion on Biological Therapy|November 17, 2015
Vedolizumab for the treatment of ulcerative colitisNeal Shahidi, Brian Bressler, Remo Panaccione
Pageof 66